Clover Health Investments, Corp. (CLOV)
| Market Cap | 1.27B -31.3% |
| Revenue (ttm) | 1.92B +40.3% |
| Net Income | -85.55M |
| EPS | -0.17 |
| Shares Out | 524.67M |
| PE Ratio | n/a |
| Forward PE | 27.33 |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 4,192,948 |
| Open | 2.400 |
| Previous Close | 2.400 |
| Day's Range | 2.350 - 2.460 |
| 52-Week Range | 1.580 - 3.920 |
| Beta | 2.25 |
| Analysts | Buy |
| Price Target | 2.90 (+19.34%) |
| Earnings Date | May 6, 2026 |
About CLOV
Clover Health Investments, Corp. provides medicare advantage plans in the United States. The company offers preferred provider organization and health maintenance organization plans to medicare-eligible individuals. It also operates Clover Assistant, a software platform for physicians to detect, identify, and manage chronic diseases. The company was founded in 2014 and is based in Wilmington, Delaware.
Financial Performance
In 2025, Clover Health Investments's revenue was $1.92 billion, an increase of 40.33% compared to the previous year's $1.37 billion. Losses were -$85.55 million, 98.9% more than in 2024.
Financial StatementsAnalyst Summary
According to 3 analysts, the average rating for CLOV stock is "Buy." The 12-month stock price target is $2.9, which is an increase of 19.34% from the latest price.
News
Clover Health to Report First Quarter 2026 Financial Results on May 6, 2026
WILMINGTON, Del., April 08, 2026 (GLOBE NEWSWIRE) -- Clover Health Investments, Corp. (Nasdaq: CLOV) (“Clover,” “Clover Health” or the “Company”), today announced that it will release its financial re...
Clover Health Empowers Members to Take Charge of Their Health Data Through HealthEx Partnership
WILMINGTON, Del., April 07, 2026 (GLOBE NEWSWIRE) -- Clover Health Investments, Corp. (Nasdaq: CLOV) (“Clover,” “Clover Health” or the “Company”), a physician enablement company committed to bringing ...
Clover Health Announces Departure of Chief Financial Officer and Appointment of Interim Chief Financial Officer; Reiterates Most Recently Issued Financial Guidance for Full Fiscal Year 2026
WILMINGTON, Del., April 01, 2026 (GLOBE NEWSWIRE) -- Clover Health Investments, Corp. (Nasdaq: CLOV) (“Clover” or the “Company”), a physician enablement company committed to bringing access to great h...
Primary Care Physician Use of Counterpart Assistant Associated with 18%–22% Fewer Flu-Related Acute Care Events Among COPD and CHF Patients
SAN FRANCISCO, March 19, 2026 (GLOBE NEWSWIRE) -- Counterpart Health, Inc. (“Counterpart”), a wholly owned subsidiary of Clover Health Investments, Corp. (Nasdaq: CLOV) (“Clover,” “Clover Health” or t...
Clover Health Investments Transcript: Leerink Global Healthcare Conference 2026
AI-driven Medicare Advantage plan reports strong growth, 95%+ retention, and expects GAAP profitability in 2026. Technology platform enables earlier diagnoses and better outcomes, with 70% of members ...
UPDATED – Moving from Pledge to Production, Clover Health is Now Live on Kno2, Participating in Recently Announced Federal Interoperability Initiatives
NOTICE: This is an updated version of a press release originally issued March 4, 2026 by Clover Health Investments, Corp. (Nasdaq: CLOV). Language has been updated to further refine the description of...
Clover Health Moves from Pledge to Production, Becomes The First Payer Live on a CMS Aligned Network
WILMINGTON, Del., March 04, 2026 (GLOBE NEWSWIRE) -- Clover Health Investments, Corp. (Nasdaq: CLOV) (“Clover,” “Clover Health” or the “Company”), a physician enablement company committed to bringing ...
Clover Health Investments Earnings Call Transcript: Q4 2025
Achieved full year Adjusted EBITDA profitability in 2025 with 38% membership growth and strong cost control. 2026 guidance targets first full year of GAAP net income profitability, 46% membership grow...
Clover Health Reports Fourth Quarter & Full Year 2025 Results; Provides Full Year 2026 Guidance
Business Highlights: Generated full year 2025 Adjusted EBITDA profitability while growing membership by 38% and Insurance revenue by 41% year-over-year Achieved industry-leading 2026 AEP growth of 53%...
Clover Health to Participate in Upcoming Leerink 2026 Global Healthcare Conference
WILMINGTON, Del., Feb. 17, 2026 (GLOBE NEWSWIRE) -- Clover Health Investments, Corp. (Nasdaq: CLOV) (“Clover,” “Clover Health” or the “Company”), today announced that its Chief Financial Officer, Pete...
Clover Health to Report Fourth Quarter and Full Year 2025 Financial Results on February 26, 2026
WILMINGTON, Del., Jan. 29, 2026 (GLOBE NEWSWIRE) -- Clover Health Investments, Corp. (Nasdaq: CLOV) (“Clover,” “Clover Health” or the “Company”), today announced that it will release its financial res...
Clover Health Investments Transcript: 44th Annual J.P. Morgan Healthcare Conference
Strong 53% membership growth and high retention were achieved through disciplined expansion and technology-driven care. The AI-powered platform enables early disease management, supporting profitabili...
Clover Health Announces 53% Growth in Medicare Advantage Membership During AEP, Increasing to 153,000 Members as of January 1, 2026; Expects First-Ever Full Year GAAP Net Income Profitability in 2026
Clover delivers market-leading Medicare Advantage growth, establishing a strong path to achieve its first-ever full year GAAP Net Income profitability in 2026. Disciplined, core-market growth, strong ...
Counterpart Health 2025 Results: How Better Clinical Decisions at Scale Improve Outcomes, Quality, and Cost
SAN FRANCISCO, Jan. 12, 2026 (GLOBE NEWSWIRE) -- Counterpart Health , Inc. (“Counterpart” or the “Company”), a leading AI-powered physician-enablement platform and subsidiary of Clover Health Investme...
Clover Health to Participate in Upcoming J.P. Morgan 2026 Healthcare Conference
WILMINGTON, Del., Dec. 16, 2025 (GLOBE NEWSWIRE) -- Clover Health Investments, Corp. (Nasdaq: CLOV) (“Clover,” “Clover Health” or the “Company”), today announced that its Chief Executive Officer, Andr...
Clover Health Investments Transcript: Citi Annual Global Healthcare Conference 2025
Strong membership growth and profitability are driven by proprietary AI-powered technology, high member retention, and a focus on core markets. Financial outlook is positive, with a four-star rating a...
Clover Health to Participate in Upcoming 2025 Citi Global Healthcare Conference
WILMINGTON, Del., Nov. 17, 2025 (GLOBE NEWSWIRE) -- Clover Health Investments, Corp. (Nasdaq: CLOV) (“Clover,” “Clover Health” or the “Company”), today announced that its Chief Financial Officer, Pete...
Clover Health Investments Transcript: UBS Global Healthcare Conference 2025
AI-driven technology is enabling earlier chronic disease management, driving strong membership and revenue growth, and improving clinical outcomes. Operational efficiencies and product expansion suppo...
Clover Health Investments Earnings Call Transcript: Q3 2025
Membership and revenue grew sharply year-over-year, but profitability was pressured by a higher mix of new members and elevated utilization. Guidance for 2025 was lowered, but strong retention, techno...
Clover Health Reports Third Quarter 2025 Results
Business Highlights: Generates third quarter year-to-date positive Adjusted EBITDA profitability, on a wide network, while growing membership by 35% and revenue by 39% year-over-year, despite a greate...
Clover Health Announces Chelsea Clinton to Step Down from Board Following Eight Years of Service
WILMINGTON, Del., Oct. 31, 2025 (GLOBE NEWSWIRE) -- Clover Health Investments, Corp. (Nasdaq: CLOV) (“Clover,” “Clover Health” or the “Company”) today announced that Chelsea Clinton, the longest-servi...
Primary Care Physician Use of Counterpart Assistant (CA) Technology Associated With Earlier Diagnosis And Less Frequent Hospitalization In Underserved Populations
New whitepaper demonstrates how CA enables primary care teams in resource-constrained settings to prevent, detect, and manage chronic disease. New whitepaper demonstrates how CA enables primary care t...
Clover Health to Participate in Upcoming 2025 UBS Global Healthcare Conference
WILMINGTON, Del., Oct. 22, 2025 (GLOBE NEWSWIRE) -- Clover Health Investments, Corp. (Nasdaq: CLOV) (“Clover,” “Clover Health” or the “Company”), today announced that its Chief Financial Officer, Pete...
Clover Health's 2026 Medicare Advantage Plans Champion Affordability and Choice
The Company Reinforces Market Position, Maintaining Comprehensive PPO Portfolio As Clover Assistant Drives Sustainable Value The Company Reinforces Market Position, Maintaining Comprehensive PPO Portf...
Counterpart Health Expands Proven Flywheel for HEDIS Excellence to Third-Party Partners
Technology platform again powers top-tier HEDIS results for Clover Health Medicare Advantage plans Technology platform again powers top-tier HEDIS results for Clover Health Medicare Advantage plans